Dr Reddys Laboratories Share Price Today - Live Blog for September 29, 2025

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.51%, reaching the current market price of ₹1,239.45. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.19%, with its current market value per share resting at ₹1,235.90. This development highlights the stock's appeal to investors.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.46% in its share price, and it currently trades at ₹1,233.00 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has surged by 0.05%, and it is currently trading at ₹1,238.00. Additionally, the stock maintains a PE ratio of 18.4000, while the industry PE is 33.8643.

Following a noteworthy 0.09% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,238.30. When it comes to valuation, this stock has a PE ratio of 18.4000, with the industry PE ratio at 33.8643.

The stock of Dr Reddys Laboratories Ltd suffered a -0.06% decline, and it currently trades at ₹1,238.10 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's stock has surged by 0.15%, and it is currently trading at ₹1,238.90. Additionally, the stock maintains a PE ratio of 18.4000, while the industry PE is 33.8643.

With a -0.40% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,235.05. Investors should examine the factors driving this decline. The stock's PE ratio is 18.4000, whereas the industry PE ratio stands at 33.8643.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.04% increase and currently trading at ₹1,240.50 per share. Investors are taking notice of this upward momentum.

With a -0.31% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,239.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.4000, whereas the industry PE ratio stands at 33.8643.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.18% boost, with the current market value at ₹1,242.90 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd experienced a -0.09% dip in its share price and is currently trading at ₹1,240.90. The stock has a PE ratio of 18.4000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a -0.09% drop in its share price and is currently trading at ₹1,240.90. With the stock's PE at 18.4000 and the industry PE at 33.8643, investors are weighing their options.

After a -0.09% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,240.90. The stock has a PE ratio of 18.4000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.07% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,244.40 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

With a -0.01% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,242.90. The stock is currently trading at a PE of 18.4000, while the industry PE is 33.8643, prompting investors to assess its value proposition.

With a -0.66% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,242.85. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.4000, while the industry PE is 33.8643.

Dr Reddys Laboratories Ltd experienced a -0.46% dip in its share price and is currently trading at ₹1,251.00. The stock has a PE ratio of 18.4000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

There was no alteration in the share price of Dr Reddys Laboratories Ltd, and it is currently trading at ₹1,255.70. This lack of change could lead investors to revisit their investment strategies and consider the stock's valuation.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.16% drop, and it's now trading at ₹1,255.15 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd plunged by -0.05%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,257.95, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's shares experienced a 0.14% uptick, and they are currently valued at ₹1,258.60, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The share price of Dr Reddys Laboratories Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,254.90, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd witnessed a -0.35% drop in its share price and is currently trading at ₹1,255.60. With the stock's PE at 18.4000 and the industry PE at 33.8643, investors are weighing their options.

Dr Reddys Laboratories Ltd's shares experienced a 0.16% uptick, and they are currently valued at ₹1,259.85, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's share price has dropped by -0.08%, a development that warrants careful analysis. Presently trading at ₹1,259.00, investors are assessing whether this presents an opportunity or a risk.

Demonstrating a commendable 0.22% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,255.15. In terms of valuation, the stock maintains a PE ratio of 18.4000, while the industry PE ratio stands at 33.8643.